首页|期刊导航|中国中医药信息杂志|丹瓜护脉口服液通过HIF-1α调控铜死亡保护2型糖尿病血管内皮细胞的机制研究

丹瓜护脉口服液通过HIF-1α调控铜死亡保护2型糖尿病血管内皮细胞的机制研究OA

Study on the Mechanism of Dangua Humai Oral Liquid in Improving Copper Death of Vascular Endothelial Cells in Type 2 Diabetic via HIF-1α

中文摘要英文摘要

目的 探讨丹瓜护脉口服液通过调控缺氧诱导因子-1α(HIF-1α)改善2型糖尿病(T2DM)血管内皮细胞铜死亡的作用机制.方法 采用网络药理学方法筛选丹瓜护脉口服液的有效成分、作用靶点及其与T2DM、氧化应激的交集靶点,构建蛋白相互作用网络并进行GO、KEGG通路富集分析.通过高脂高糖饲料联合链脲佐菌素诱导T2DM大鼠模型,将大鼠随机分为正常组、模型组、丹瓜护脉口服液组、HIF-1α抑制剂(PX-478)组、丹瓜护脉口服液联合PX-478组及二甲双胍组,予相应干预14周,生化法和ELISA检测糖脂代谢指标[空腹血糖(FBG)、餐后2 h血糖(2 hBG),血清糖化血红蛋白(HbA1c)、总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)],HE染色观察胸主动脉组织形态,免疫组化法检测胸主动脉组织HIF-1α蛋白表达,ELISA检测血管内皮功能和氧化应激指标[内皮素-1(ET-1)、血管内皮生长因子(VEGF)、胱天蛋白酶-3(Caspase-3)、一氧化氮合酶(NOS)],红氨酸染色法检测铜盐沉积情况.结果 网络药理学分析筛选出丹瓜护脉口服液与T2DM和氧化应激的交集靶点224个,HIF-1α为核心靶点之一.动物实验显示,丹瓜护脉口服液能显著降低模型大鼠FBG、2 hBG、HbA1c、TC、TG、LDL-C及ET-1、Caspase-3水平,升高HDL-C、VEGF、NOS水平及HIF-1α蛋白表达(P<0.05,P<0.01,P<0.001),并减轻胸主动脉内皮结构损伤和铜盐沉积;HIF-1α受抑制后,糖脂代谢紊乱、氧化应激、铜离子异常聚集及血管内皮损伤加重;丹瓜护脉口服液与PX-478联合应用能一定程度改善由PX-478引发的糖脂代谢紊乱、氧化应激及铜超载.结论 丹瓜护脉口服液可能通过上调HIF-1α表达,减轻铜离子异常积聚,抑制铜死亡进程,缓解由此引发的氧化应激,发挥对T2DM血管内皮的保护作用.

Objective To investigate the mechanism of Dangua Humai Oral Liquid(DGHM)in improving copper death(cuproptosis)of vascular endothelial cells in type 2 diabetes mellitus(T2DM)rats through hypoxia-inducible factor-1α(HIF-1α).Methods Network pharmacology was used to screen the active components,potential targets of DGHM,and its intersection targets with T2DM and oxidative stress.Protein-protein interaction network construction and GO and KEGG enrichment analyses were performed.A T2DM rat model was induced by a high-fat and high-sucrose diet combined with streptozotocin injection.The rats were randomly divided into normal group,model group,DGHM group,HIF-1α inhibitor(PX-478)group,DGHM combined with PX-478 group,and Metformin control group.After 14 weeks of intervention,glycolipid metabolism indicators including FBG,2 hBG,HbA1c,TC,TG,HDL-C and LDL-C were assessed by biochemical methods and ELISA;the morphological structure of the thoracic aorta was observed by HE staining;HIF-1α protein expression in thoracic aortic tissue was detected by immunohistochemistry;vascular endothelial function and oxidative stress markers including endothelin-1(ET-1),vascular endothelial growth factor(VEGF),Caspase-3 and nitric oxide synthase(NOS)were measured by ELISA;copper deposition was detected by rubeanic acid staining.Results Network pharmacology identified 224 intersection targets with T2DM and oxidative stress,with HIF-1α being one of the core targets.Animal experiments showed that DGHM could significantly reduce FBG,2 hBG,HbA1c,TC,TG,LDL-C,ET-1 and Caspase-3 levels,increase HDL-C,VEGF,NOS activity,and HIF-1α protein expression of model rats(P<0.05,P<0.01,P<0.001),and alleviate structural damage and copper deposition in the thoracic aortic endothelium.After inhibition of HIF-1α,glucose and lipid metabolism disorders,oxidative stress,abnormal copper ion aggregation,and vascular endothelial damage worsened.The combination of DGHM and PX-478 could improve to some extent the glucose and lipid metabolism disorders,oxidative stress,and copper overload caused by PX-478.Conclusion DGHM may exert a protective effect on T2DM vascular endothelium by upregulating HIF-1α expression,reducing abnormal accumulation of copper ions,inhibiting copper death process,alleviating oxidative stress caused by it.

靳霖溪;何卫东;王志塔;陈奇炜;韩壮;姚淑红;阮怡;洪鑫淼;衡先培;杨柳清;李亮

福建中医药大学附属人民医院,福建 福州 350004福建中医药大学附属人民医院,福建 福州 350004福建中医药大学附属人民医院,福建 福州 350004福建中医药大学附属人民医院,福建 福州 350004福建中医药大学附属人民医院,福建 福州 350004福建中医药大学附属人民医院,福建 福州 350004福建中医药大学附属人民医院,福建 福州 350004福建中医药大学附属人民医院,福建 福州 350004福建中医药大学附属人民医院,福建 福州 350004福建中医药大学附属人民医院,福建 福州 350004福建中医药大学附属人民医院,福建 福州 350004

医药卫生

2型糖尿病丹瓜护脉口服液网络药理学缺氧诱导因子-1α氧化应激铜死亡

type 2 diabetes mellitusDangua Humai Oral Liquidnetwork pharmacologyhypoxia-inducible factor-1αoxidative stresscuproptosis

《中国中医药信息杂志》 2026 (6)

28-37,10

国家自然科学基金(82205071、82074308、82274389)福建省自然科学基金(2023J01149、2023J01844、2024J01771、2024J01758)

10.19879/j.cnki.1005-5304.202511121

评论